Claudia Agabiti Rosei Selected Research

Fibronectins (Fibronectin)

1/2018

Changes in extracellular matrix in subcutaneous small resistance arteries of patients with essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Agabiti Rosei Research Topics

Disease

3	Hypertension (High Blood Pressure) 03/2022 - 01/2017
3	Essential Hypertension 01/2018 - 04/2010
1	Hypercholesterolemia 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Hypertensive Crisis 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Heart Failure 06/2017
1	Vascular System Injuries 01/2017
1	Inflammation (Inflammations) 01/2017
1	Mood Disorders (Mood Disorder) 03/2016
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015
1	Amyloidosis 01/2015
1	Type 2 Diabetes Mellitus (MODY) 10/2014
1	Pheochromocytoma 06/2008
1	Pneumoperitoneum 06/2008
1	Neoplasms (Cancer) 06/2008

Drug/Important Bio-Agent (IBA)

2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 10/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	LDL CholesterolIBA 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2022
1	Ezetimibe (Zetia)FDA Link 03/2022
1	elastin microfibril interface located protein (emilin)IBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	DiureticsIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	Laminin (Merosin)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2017
1	Enalapril FDA LinkGeneric 10/2017
1	lercanidipineIBA 10/2017
1	Angiotensin IIIBA 01/2017
1	SaltsIBA 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	Retinaldehyde (Retinal)IBA 10/2014
1	aliskiren FDA Link 10/2014
1	Ramipril (Altace)FDA LinkGeneric 10/2014
1	Ethanol (Ethyl Alcohol)IBA 04/2010
1	FlavonoidsIBA 04/2010
1	Vasodilator Agents (Vasodilators)IBA 04/2010
1	CatecholaminesIBA 06/2008

Therapy/Procedure

1	Secondary Prevention 03/2022
1	Therapeutics 06/2017
1	Adrenalectomy 06/2008